0914 GMT - CVS Group's disposal of its crematorium division helps simplify the company's structure and sheds a business unit that provides a minor contribution to earnings, Davy Research analyst Colin Grant says. The analyst adds in a research note that the division can be considered non-core. "Overall, we view this disposal as opportunistic and attractive," Grant says. At a sale price of 42.4 million pounds, the disposal underscores the undervaluation of the rest of the company, the analyst says. The company expects to post a one-off 32.0 million pounds gain in its year-end account from the sale. CVS Group's shares trade 2.4% higher at 1,030 pence. (pierre.bertrand@wsj.com)
(END) Dow Jones Newswires
April 24, 2025 05:14 ET (09:14 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。